Navigation Links
Piramal Healthcare Limited Acquires Molecular Imaging Development Portfolio of Bayer Pharma
Date:4/15/2012

MUMBAI, India, April 15, 2012 /PRNewswire/ -- Piramal Healthcare Limited [NSE: PIRHEALTH, BSE: 500302] ("Piramal"), announced that it has signed an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG ("Bayer") through its newly created subsidiary – Piramal Imaging SA. The portfolio includes rights to florbetaben, which is in the final stages of its Phase III clinical trials. First Phase III results will be presented on April 25th 2012 at the American Academy of Neurology's 64th Annual Meeting in New Orleans.

Florbetaben is a PET tracer for the detection of beta-Amyloid plaque deposition in the brain, which is the pathological hallmark of disease in probable Alzheimer's disease patients. Detection of beta-Amyloid depositions is expected to result in earlier diagnosis and more specific treatment of Alzheimer's disease.

The Phase III trial showed that PET imaging with florbetaben reliably detects beta-Amyloid in the brain during life with great accuracy and thus shows value as a potential tool to aid in the diagnosis and assessment of Alzheimer's disease. All study endpoints were met. The visual assessment procedure proposed for routine clinical practice demonstrated 100% sensitivity and 92% specificity with excellent inter-reader agreement (kappa = 0.88).

Commenting on the transaction, Mr. Ajay Piramal, Chairman Piramal Group, said, "This is the second acquisition of late stage assets after our acquisition of assets of BioSyntech in 2011, where we have recently received the European CE mark approval for an innovative bio-orthopaedic product for cartilage repair, BST-CarGel®, which enables the company to commercialize BST-CarGel® in all of the countries in the European Union. We plan to build a promising portfolio in the pharma space, including our newly acquired Molecular Imaging assets, which will help us create a global branded pharma business.
'/>"/>

SOURCE Piramal Healthcare Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
2. Sunpeaks Ventures Enters Agreement with UK Based Healthcare Firm to Introduce Clotamin to UK and European Union Countries
3. IOD Incorporated Advises Healthcare Providers to Stay the Course in Preparation for ICD-10
4. TSI Healthcare Customers Receive Government Incentives for Meeting EHR Requirements
5. MarketsandMarkets: Global Home Healthcare Market Worth $296 Billion by 2016
6. Savient Pharmaceuticals to Present at the Imperial Capital Healthcare Investor Forum
7. Fortis Healthcare Signs Agreement Giving Indias Fastest-Growing Hospital Chain Access to Masimos State-of-the-Art Noninvasive Patient Monitoring Solutions
8. Modern Healthcare and ECRI Institute Launch New Technology Price Index
9. New White Paper Offers Model for Measuring Financial Impact of Reducing Toileting-Related Falls in Healthcare Facilities
10. Huntzinger Management Group, Inc., (HMG) Further Invests in Healthcare Industrys "90 Percent"
11. Annual Biotech and Healthcare Conferences Being Held in Boston MA, Summer 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Uroplasty, Inc. (NASDAQ: UPI ), a ... proprietary products to treat voiding dysfunctions, today announced that ... on Tuesday, March 10, 2015. Rob Kill , ... Financial Officer, will present at 4:00 p.m. Pacific Time ... conference at the Ritz Carlton in Laguna ...
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015  Chiasma, ... its lead product for the orphan condition acromegaly, today ... financing round. Participants in the financing included new investors ... blue chip public investment fund, as well as existing ... Abingworth and ARCH Venture Partners. Chiasma ...
(Date:2/26/2015)... Feb. 27, 2015  Finesse expands office in ... announced the expansion of its operations in ... mid-March and access for customers is expected shortly afterward. ... located adjacent to the current office, the new premises ... team and allow Finesse to bring on more service ...
Breaking Medicine Technology:Uroplasty to Participate in the 27th Annual ROTH Conference 2Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3New Finesse Office in United Kingdom 2
... February 23 BN,ImmunoTherapeutics, Inc. today provided updated ... vaccine, MVA-BN(R)-HER2, in development as,therapy of metastatic breast ... its primary endpoint with regards to safety and ... immune response was,detected in approximately 70% of evaluated ...
... An international team of,researchers has evaluated ... the knee, and the results have been ... journal "Osteoarthritis and Cartilage".,The researchers followed 376 ... treatments. After six months as well as ...
Cached Medicine Technology:BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine 2BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine 3New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years 2
(Date:2/27/2015)... Schenectady, New York (PRWEB) February 27, 2015 ... has been named one of the Best Companies to ... , “Transfinder recognizes the importance of creating a great ... a demanding – yet professionally fulfilling – environment. There’s ... doing great work together,” said Antonio Civitella, president and ...
(Date:2/27/2015)... NC (PRWEB) February 27, 2015 ... addressing the unique challenges faced by women with ... Leadership Institute. The Institute, which aims to develop ... nationwide, is scheduled for the weekend of April ... process, a rigorous selection of participants was made ...
(Date:2/27/2015)... NV (PRWEB) February 27, 2015 BaliniSports ... collaborating with the online fitness social platform FITMOO. The ... quality products and holistic philosophy behind BaliniSports. Users of ... in an intimate way and discover apparel that will ... brand that uses environmentally friendly and socially conscious methods ...
(Date:2/27/2015)... February 27, 2015 Several studies showing ... heart failure have made headline news recently. However, all ... research appearing in this month’s STEM CELLS Translational Medicine ... in treating children with congenital heart diseases that can ... by researchers at the Mayo Clinic in Rochester, Minn., ...
(Date:2/27/2015)... 27, 2015 The Obrella Insider ... in Florida " report today. To determine the ... U.S. Census Bureau survey, considering only Florida cities ... the survey. , The report visualizes compelling commuter ... commuting and a breakdown of commute durations. , ...
Breaking Medicine News(10 mins):Health News:Transfinder Named a Best Company to Work for in New York State 2Health News:DiabetesSisters Announces 2015 Leadership Institute for April 24-26, 2015 2Health News:BaliniSports Announces Collaboration with FITMOO 2Health News:Study Shows Stem Cells Have Potential to Help Kids’ Hearts, Too 2Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2
... Focus is system that regulates blood pressure and fluid ... News) -- New research is shedding some light on ... cause miscarriage and death in pregnant women. , "Preeclampsia ... 10 percent of all pregnancies in the United States," ...
... (FA) is a rare and dangerous disease, new laboratory research ... shows it may lead researchers toward clues in more common ... a study published in the Sept. 11 issue of the ... proteins to DNA damage sites is controlled by replication in ...
... the biggest student drinking problems have so far failed to turn ... in the September issue of the Journal of Studies on ... students, alcohol habits showed little change over a dozen years. In ... two weeks; in 2005, 56 percent said the same. And although ...
... blind and visually impaired often rely on others to provide ... with this method is that it doesn,t give them the ... Lahav of Tel Aviv University,s School of Education and Porter ... to the blind, Dr. Lahav has invented a new software ...
... Administration,s (FDA) recent decision to approve the radioimmunotherapy (RIT) ... lymphoma (NHL). "This is welcome news for ... Ph.D., president of SNM and director of nuclear medicine ... "We,ve known for some time that RIT works extremely ...
... Television journalist Veronica ... and now directs her brother,s story to the White House , ... Los Angeles, CA (PRWeb) September 10, 2009 -- After ... brought the tale of her brother Eric,s tragic battle against health care red tape to ...
Cached Medicine News:Health News:Research Seeks Cause of Preeclampsia 2Health News:Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins 2Health News:Heavy-drinking colleges showing no improvements 2Health News:Virtual maps for the blind 2Health News:Virtual maps for the blind 3Health News:SNM applauds FDA's decision to approve Zevalin 2Health News:Television Journalist Veronica De La Cruz Brings Her Brother's Story from L.A. to White House in Fight for Health Care Reform 2Health News:Television Journalist Veronica De La Cruz Brings Her Brother's Story from L.A. to White House in Fight for Health Care Reform 3
... prints labels up to 8.5 ... It is ideal for wide ... chemical drum labels, primary metal ... banner-sized labels and pallet and ...
... Korchek Technologies CareChek Tx, which ... a software device for blood ... match the patient to the ... bedside before administering a transfusion.The ...
... Management system ensures your patients are receiving ... BloodTrack SafeTx uses the AutoPPI™ barcoded wristband ... collection to transfusion. SafeTx checks that the ... need for bedside paperwork and associated transcription ...
... The automated patient ID verification and laboratory ... the identity of the phlebotomist or nurse, the ... request. If proper verification is made, a bar ... the bedside. Its unique design simplifies and eliminates ...
Medicine Products: